Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Recommended Conferences
Cardiology & Cardiac Surgery 2020
New York, USA
Clinical Cardiology
San Francisco, USA
Cardiology Summit China
Brussels, BelgiumComplete Response in Patient with Metastatic Breast Cancer Treated with Metronomic Chemotherapy
Background: Here we report a case of complete response in patient with Metastatic Breast Cancer treated by metronomic Chemotherapy.
Case presentation : A 51 years old woman underwent righy mastectomy in may 2008. She performed fi rst- line chemotherapy with doxorubicin every 21 days. The CT revaluation after ten cycle showed a partial response to treatment. It was decided to stop the treatment with doxorubicin and to start a metronomic therapy with cyclophosphamide 50 mg daily orally and Methotrexate 2.5 mg twice daily. After two months of this maintenance treatment, the CT scan showed a complete response. The metronomic treatment is still ongoing, and after 45 months the patient maintains a complete response.
Conclusion : This clinical case also highlights how suitable metronomic chemotherapy can be as maintenance therapy, allowing long-term treatment with no relevant toxicity.
- Share this page
